GlassScriptPhysician profile
Tara L Peterson
NPI 1235108457
$1,889.57
in general payments reported to CMS, 2019-2025
20 companies · $420 in 2025
The $420 reported for 2025 was more than what a typical Gerontology (Nurse Practitioner) provider received nationally (typical 2025 total: $180).
See the full distribution for Gerontology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $89.14 · 2022: $311 · 2023: $454 · 2024: $616 · 2025: $420.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,489.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,489.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aimmune Therapeutics, INC. | $383.41 | 2024-2025 | Zenpep |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $229.76 | 2022-2025 | Xifaxan |
| Genzyme Corporation | $204.88 | 2022-2025 | |
| Abbvie INC. | $162.35 | 2022-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $156.59 | 2021-2025 | Entyvio, Gattex |
| Janssen Biotech, INC. | $145.04 | 2021-2025 | Tremfya, Stelara, Simponi |
| Celgene Corporation | $142.80 | 2022-2023 | Zeposia |
| Ironwood Pharmaceuticals, INC | $80.79 | 2023 | Linzess |
| Regeneron Healthcare Solutions, INC. | $74.46 | 2022-2024 | Dupixent |
| Madrigal Pharmaceuticals | $60.65 | 2025 | Rezdiffra |
| Intercept Pharmaceuticals, INC. | $46.43 | 2024-2025 | |
| Gilead Sciences, INC. | $41.42 | 2024 | |
| Amgen INC. | $40.35 | 2022 | |
| Phathom Pharmaceuticals, INC. | $33.26 | 2025 | Voquezna |
| Qol Medical, LLC | $20.35 | 2023 | Sucraid |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $16.13 | 2022 | |
| Pfizer INC. | $15.85 | 2025 | |
| Ferring Pharmaceuticals INC. | $12.72 | 2021 | |
| Baxter Healthcare | $12.67 | 2022 | |
| Organon LLC | $9.66 | 2023 | Hadlima |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tara Peterson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.